Plasmodium Immunotherapy for Advanced Ovarian Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Plasmodium Immunotherapy for Advanced Ovarian Cancer	Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease	Not yet recruiting	Phase 2 / Phase 3	2024-07-22		NCT05924776

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.	1
The Third Affiliated Hospital of Southern Medical University	13

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Third Affiliated Hospital of Southern Medical University	Guangzhou	China	6

Clinical trials